Phase I/II

Sensorion, Montpellier, France & Cambridge, Mass., September 3, 2026 Sensorion announced that it has received Clinical Trial Authorization (CTA)...

PALO ALTO, Calif., September 2, 2026 BridgeBio Pharma, Inc. announced plans to present new clinical data on the impact...

LEXINGTON, Mass. and AMSTERDAM, September 2, 2026 uniQure N.V. announced the submission of a Biologics License Application (BLA) to...